Severity 2 of 5
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Severity 2 (Moderate) recalls cover minor labeling errors, low-risk contamination, and voluntary precautionary recalls. The agency's own classification is typically FDA Class III, or the issue is something like incomplete instructions or a small UPC mismatch where the product itself is safe but doesn't meet documentation requirements. Use the same brand-name product safely; follow the manufacturer's instructions for return or exchange if you want a refund.
The full rubric is on the methodology page. Severity is computed deterministically from the agency’s own classification plus the source text — no editorial vibes.
Aidapak Services, LLC is recalling 5,000-unit Cholecalciferol tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Clindamycin HCL capsules because they may have been mislabeled as Melatonin tablets. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Montelukast Sodium chew tablets that may be mislabeled as Dicyclomine HCL. The error could lead to patients taking the wrong medication.
Aidapak Services, LLC is recalling 1,109 docusate calcium capsules because they may have been mislabeled as other medications. The affected products were distributed in four western states.
Aidapak Services, LLC is recalling Duloxetine HCl DR capsules because they may be mislabeled with other medications. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Verapamil HCL ER capsules because they may have been mislabeled as Febuxostat tablets.
Aidapak Services is recalling Saccharomyces Boulardii capsules because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Lactobacillus Acidophilus tablets because they may have been mislabeled as Repaglinide.
Aidapak Services is recalling Valsartan 160 mg tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services is recalling 2 mg nicotine polacrilex lozenges because they may have been mislabeled as other prescription drugs. The affected products were distributed in four western states.
Nellcor Puritan Bennett is correcting operator and service manuals for PB700 and PB840 ventilators to clarify the operational life of the oxygen sensor.
Novartis Consumer Health is recalling Theraflu Multi-Symptom Severe Cold powder packets because they may contain foreign substances.
Aidapak Services, LLC is recalling Raltegravir 400 mg tablets because they may be mislabeled as other medications. The recall covers specific lots distributed in four western states.
Aidapak Services, LLC is recalling Niacin ER 500 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services is recalling sitaGLIPtin phosphate tablets because they may be mislabeled as Lactobacillus or Cyanocobalamin.
Aidapak Services, LLC is recalling 15 mg Pioglitazone tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Potassium Acid Phosphate 500 mg tablets because they may have been mislabeled as Prednisone 20 mg.
Aidapak Services is recalling Atomoxetine HCL capsules because they may be mislabeled as Lovastatin tablets. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Midodrine HCL 2.5 mg tablets that may have been mislabeled as Pioglitazone HCL 15 mg.
Aidapak Services is recalling Mycophenolate Mofetil capsules that may have been mislabeled as Pramipexole Di-HCl tablets.
Aidapak Services, LLC is recalling Nebivolol HCL 5 mg tablets because they may have been mislabeled as Thyroid or Rasagiline Mesylate.
Aidapak Services, LLC is recalling Levothyroxine Sodium tablets that may have been mislabeled as Omega-3 Fatty Acid capsules.
Aidapak Services, LLC is recalling Sotalol HCL 160 mg tablets that may have been mislabeled as Disulfiram 250 mg.
Aidapak Services, LLC is recalling Phenobarbital 97.2 mg tablets because they may have been mislabeled as 64.8 mg tablets.
Aidapak Services, LLC is recalling Bumetanide 0.5 mg tablets because they may have been mislabeled as Erythromycin DR EC 250 mg.